SCHEMBL17875819

SCHEMBL17875819

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)-c3ccc(-n5c6ccccc6c6ccccc65)cc3COC4)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ATM Q13315 2/20 0.37
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
HDAC4 P56524 1/20 0.33
TYRO3 Q06418 1/20 0.33
NTRK2 Q16620 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
MAPT P10636 3/20 0.32
RECQL P46063 1/20 0.32
TDP2 O95551 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MEN1 O00255 1/20 0.31
APAF1 O14727 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875854 0.95 KDM4E (0.37) L3MBTL1KDM4EATMALDH1A1LMNA
SCHEMBL17875883 0.94 KDM4E (0.40) L3MBTL1KDM4EATMALDH1A1EDNRB
SCHEMBL17875820 0.90 KDM4E (0.40) L3MBTL1KDM4EATMALDH1A1LMNA
SCHEMBL17875818 0.88 CYP11B1 (0.38) TDP2
SCHEMBL17875717 0.85 ATM (0.37) L3MBTL1KDM4EATMLMNAEDNRB
SCHEMBL17875869 0.85 KDM4E (0.40) L3MBTL1KDM4EATMALDH1A1LMNA
SCHEMBL17877858 0.84 PRF1 (0.35) EDNRBEDNRAPRKDC
SCHEMBL17875907 0.84 PIK3CA (0.34) L3MBTL1KDM4EATMEDNRBEDNRA
SCHEMBL17875813 0.84 NPC1 (0.36) L3MBTL1KDM4EATMALDH1A1LMNA
SCHEMBL17875815 0.84 SMN1; SMN2 (0.33) L3MBTL1KDM4EATMALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 L3MBTL1 768/4885KDM4E 3120/4885ATM 1164/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 L3MBTL1 768/4885KDM4E 3120/4885ATM 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.